Úvod Laboratorní plasty Zkumavky Microcentrifuge Tube 1.5 ml Microcentrifuge Tube SALSA MLPA P239 BRCA1 region probemix - 100 reactions

SALSA MLPA P239 BRCA1 region probemix - 100 reactions

SALSA MLPA P239 BRCA1 region probemix - 100 reactions

application: Breast cancer
region: BRCA1 region Detailní informace

Cena s DPH € 1 147.08
Cena bez DPH € 948.00
 100 react
Dostupnost Skladem
Kód produktu P239-100R

Nejnovější informace o produktu naleznete exklusivně na stránkách výrobce MRC-Holland www.mlpa.com (nové okno)

Detailní popis SALSA MLPA P239 BRCA1 region probemix - 100 reactions

P239-025R SALSA MLPA P239 BRCA1 region probemix – 100 rxn

description
This SALSA® MLPA® P239 BRCA1 region probemix can be used to characterize BRCA1 deletions/duplications that extend to the region before exon 1 or after exon 24. Defects in the BRCA1 gene on human chromosome 17q21 are an important cause of hereditary breast cancer. For primary screening of BRCA1, we recommend using SALSA® MLPA® probemix P002. SALSA® MLPA® probemix P239 BRCA1 region is developed for research purposes to investigate the extent of BRCA1 deletions/duplications.

This probemix contains 11 probes for the upstream region of BRCA1 which include probes for the NBR1 and NBR2 genes and the BRCA1 pseudogene, which are located immediately upstream of the BRCA1 promoter region. Furthermore, this probemix contains five probes for BRCA1. Six probes for the downstream region of BRCA1, including the VAT1 and RND2 genes, are also included. In addition, 10 reference probes are included in this probemix, detecting several different autosomal chromosomal locations.

This SALSA® MLPA® probemix is designed to detect deletions/duplications of one or more sequences in the above mentioned chromosomal BRCA1 region in a DNA sample. Heterozygous deletions of recognition sequences should give a 35-50% reduced relative peak area of the amplification product of that probe. Note that a mutation or polymorphism in the sequence detected by a probe can also cause a reduction in relative peak area, even when not located exactly on the ligation site! In addition, some probe signals are more sensitive to sample purity and small changes in experimental conditions. Therefore, deletions and duplications detected by MLPA should always be confirmed by other methods. Not all deletions and duplications detected by MLPA will be pathogenic; users should always verify the latest scientific literature when interpreting their findings.  

Kontaktujte nás

BIOGEN PRAHA s.r.o.
Ke sv. Izidoru 2293/4A
140 00 PRAHA 4

Tel.: +420 241 401 693
Fax: +420 241 401 694
E-mail: biogen@biogen.cz

Novinky na e-mail

Vaše osobní údaje nejsou nikde zveřejňovány a splňují požadavky GDPR.